Idiopathic Macular Telangiectasia Type 2: The Progressive Vasculopathy

2013 ◽  
Vol 23 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Michael Engelbert ◽  
Lawrence A. Yannuzzi
Keyword(s):  
Macular Telangiectasia ◽  
Macular Telangiectasia Type 2 ◽  
Idiopathic Macular Telangiectasia

IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2: DISTRIBUTION OF MACULAR PIGMENT AND FUNCTIONAL INVESTIGATIONS

Retina ◽  
2010 ◽  
Vol 30 (4) ◽  
pp. 586-595 ◽  
Author(s):  
MEIKE B. ZEIMER ◽  
BJÖRN PADGE ◽  
BRITTA HEIMES ◽  
DANIEL PAULEIKHOFF
Keyword(s):  
Macular Pigment ◽  
Macular Telangiectasia ◽  
Macular Telangiectasia Type 2 ◽  
Idiopathic Macular Telangiectasia

Idiopathic macular telangiectasia type 2, stage V or proliferative stage: Multimodal imaging

2021 ◽  
Author(s):  
J.L. Sánchez-Vicente ◽  
J. de las Morenas-Iglesias ◽  
B. González-Jáuregui-López ◽  
T. Rueda-Rueda ◽  
Á. Espiñeira-Periñán ◽  
...  
Keyword(s):  
Multimodal Imaging ◽  
Macular Telangiectasia ◽  
Proliferative Stage ◽  
Macular Telangiectasia Type 2 ◽  
Idiopathic Macular Telangiectasia

Efficacy of Macular Hole Surgery in Patients with Idiopathic Macular Telangiectasia Type 2

2020 ◽  
Vol 4 (5) ◽  
pp. 494-497
Author(s):  
Alexander G. Miller ◽  
Rohit Chandra ◽  
Charles Pophal ◽  
Jerome P. Schartman ◽  
Joan H. Hornik ◽  
...  
Keyword(s):  
Macular Hole ◽  
Macular Hole Surgery ◽  
Macular Telangiectasia ◽  
Macular Telangiectasia Type 2 ◽  
Idiopathic Macular Telangiectasia

scholarly journals Tamoxifen Use in a Patient with Idiopathic Macular Telangiectasia Type 2

2018 ◽  
Vol 9 (1) ◽  
pp. 60-66 ◽  
Author(s):  
Alice Behrens ◽  
Ahmed Sallam ◽  
John Pemberton ◽  
Sami Uwaydat
Keyword(s):  
Progressive Disease ◽  
Optical Coherence Tomography Angiography ◽  
Patient Support ◽  
Unique Case ◽  
Macular Telangiectasia ◽  
Crystalline Deposits ◽  
Macular Telangiectasia Type 2 ◽  
Idiopathic Macular Telangiectasia ◽  
Partial Reversal

Crystalline deposits and neurosensory retinal cavitary changes can develop in both tamoxifen retinopathy and nonproliferative idiopathic macular telangiectasia type 2 (MacTel2). MacTel2 is typically differentiated from tamoxifen retinopathy based on the presence of late leakage and mid-phase telangiectatic vessels on fluorescein angiography (FA) and the presence of hyperautofluorescence. Unlike MacTel2, tamoxifen retinopathy is known to be a progressive disease and the cessation of tamoxifen results in resolution of retinopathy. We report a unique case of nonproliferative MacTel2 in a 36-year-old Hispanic woman with tamoxifen use and the vision outcome 30 months after cessation of tamoxifen. The FA and optical coherence tomography angiography findings of this patient support the diagnosis of MacTel2, but her cessation of tamoxifen led to partial reversal of the topographic findings and improvement in visual acuity. This patient is also unique in the unusually young age of presentation for MacTel2. Our case supports that there are common pathways in the pathogenesis of tamoxifen retinopathy and MacTel2, and tamoxifen use could potentially accelerate foveal atrophy in patients with MacTel2.

Sign in / Sign up

Export Citation Format

Share Document